ClinicalTrials.govpublic full text
Is Anti-Factor Xa Associated With Outcome in Patients With Critical COVID-19 on Low-Molecular-Weight Heparin?
covid19, thromboembolism, bleeding, low-molecular-weight heparin, anti-factor xa, critical care, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847997
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.